DE eng

Search in the Catalogues and Directories

Page: 1 2 3
Hits 1 – 20 of 44

1
Language Disorder in Progressive Supranuclear Palsy and Corticobasal Syndrome: Neural Correlates and Detection by the MLSE Screening Tool. ...
Peterson, Katie A; Jones, P Simon; Patel, Nikil. - : Apollo - University of Cambridge Repository, 2021
BASE
Show details
2
Language Disorder in Progressive Supranuclear Palsy and Corticobasal Syndrome: Neural Correlates and Detection by the MLSE Screening Tool ...
Peterson, Katie A.; Jones, P. Simon; Patel, Nikil. - : Apollo - University of Cambridge Repository, 2021
BASE
Show details
3
Language impairment in progressive supranuclear palsy and corticobasal syndrome
Peterson, Katie A.; Patterson, Karalyn; Rowe, James B.. - : Springer Berlin Heidelberg, 2021. : Journal of Neurology, 2021
BASE
Show details
4
Metabolomic changes associated with frontotemporal lobar degeneration syndromes
Murley, Alexander G.; Jones, P. Simon; Coyle Gilchrist, Ian; Bowns, Lucy; Wiggins, Julie; Tsvetanov, Kamen A.; Rowe, James B.. - : Springer Berlin Heidelberg, 2021. : Journal of Neurology, 2021
Abstract: Funder: Holt Fellowship ; Funder: Cambridge Centre for Parkinson plus ; Funder: National Institute for Health Research; doi: http://dx.doi.org/10.13039/501100000272 ; Abstract: Objective: Widespread metabolic changes are seen in neurodegenerative disease and could be used as biomarkers for diagnosis and disease monitoring. They may also reveal disease mechanisms that could be a target for therapy. In this study we looked for blood-based biomarkers in syndromes associated with frontotemporal lobar degeneration. Methods: Plasma metabolomic profiles were measured from 134 patients with a syndrome associated with frontotemporal lobar degeneration (behavioural variant frontotemporal dementia n = 30, non fluent variant primary progressive aphasia n = 26, progressive supranuclear palsy n = 45, corticobasal syndrome n = 33) and 32 healthy controls. Results: Forty-nine of 842 metabolites were significantly altered in frontotemporal lobar degeneration syndromes (after false-discovery rate correction for multiple comparisons). These were distributed across a wide range of metabolic pathways including amino acids, energy and carbohydrate, cofactor and vitamin, lipid and nucleotide pathways. The metabolomic profile supported classification between frontotemporal lobar degeneration syndromes and controls with high accuracy (88.1–96.6%) while classification accuracy was lower between the frontotemporal lobar degeneration syndromes (72.1–83.3%). One metabolic profile, comprising a range of different pathways, was consistently identified as a feature of each disease versus controls: the degree to which a patient expressed this metabolomic profile was associated with their subsequent survival (hazard ratio 0.74 [0.59–0.93], p = 0.0018). Conclusions: The metabolic changes in FTLD are promising diagnostic and prognostic biomarkers. Further work is required to replicate these findings, examine longitudinal change, and test their utility in differentiating between FTLD syndromes that are pathologically distinct but phenotypically similar.
Keyword: Corticobasal syndrome; Frontotemporal dementia; Frontotemporal lobar degeneration; Metabolomics; Original Communication; Primary progressive aphasia; Progressive supranuclear palsy
URL: https://doi.org/10.17863/CAM.66825
https://www.repository.cam.ac.uk/handle/1810/319704
BASE
Hide details
5
Language Disorder in Progressive Supranuclear Palsy and Corticobasal Syndrome: Neural Correlates and Detection by the MLSE Screening Tool
Peterson, Katie A.; Jones, P. Simon; Patel, Nikil. - : Frontiers Media S.A., 2021. : Frontiers in Aging Neuroscience, 2021
BASE
Show details
6
Language Disorder in Progressive Supranuclear Palsy and Corticobasal Syndrome: Neural Correlates and Detection by the MLSE Screening Tool.
In: essn: 1663-4365 ; nlmid: 101525824 (2021)
BASE
Show details
7
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures.
In: Alzheimer's & dementia : the journal of the Alzheimer's Association, vol 16, iss 1 (2020)
BASE
Show details
8
Depressive Symptom Profiles Predict Specific Neurodegenerative Disease Syndromes in Early Stages.
Shdo, Suzanne M; Ranasinghe, Kamalini G; Sturm, Virginia E. - : eScholarship, University of California, 2020
BASE
Show details
9
Depressive Symptom Profiles Predict Specific Neurodegenerative Disease Syndromes in Early Stages.
Shdo, Suzanne M; Ranasinghe, Kamalini G; Sturm, Virginia E. - : eScholarship, University of California, 2020
BASE
Show details
10
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures.
In: Alzheimer's & dementia : the journal of the Alzheimer's Association, vol 16, iss 1 (2020)
BASE
Show details
11
Metabolomic changes associated with frontotemporal lobar degeneration syndromes. ...
Murley, Alexander; Jones, Simon; Coyle Gilchrist, Ian. - : Apollo - University of Cambridge Repository, 2020
BASE
Show details
12
Metabolomic changes associated with frontotemporal lobar degeneration syndromes ...
Murley, Alexander G.; Jones, P. Simon; Coyle Gilchrist, Ian. - : Apollo - University of Cambridge Repository, 2020
BASE
Show details
13
Metabolomic changes associated with frontotemporal lobar degeneration syndromes ...
Murley, Alexander G.; Jones, P. Simon; Coyle Gilchrist, Ian. - : Apollo - University of Cambridge Repository, 2020
BASE
Show details
14
Metabolomic changes associated with frontotemporal lobar degeneration syndromes.
Murley, Alexander; Jones, Simon; Coyle Gilchrist, Ian. - : Springer Science and Business Media LLC, 2020. : J Neurol, 2020
BASE
Show details
15
Behavioural disinhibition in the syndromes associated with frontotemporal lobar degeneration
Murley, Alexander. - : University of Cambridge, 2020
BASE
Show details
16
Metabolomic changes associated with frontotemporal lobar degeneration syndromes
Murley, Alexander G.; Jones, P. Simon; Coyle Gilchrist, Ian. - : Springer Berlin Heidelberg, 2020. : Journal of Neurology, 2020
BASE
Show details
17
Factors that predict diagnostic stability in neurodegenerative dementia.
In: Journal of neurology, vol 266, iss 8 (2019)
BASE
Show details
18
Factors that predict diagnostic stability in neurodegenerative dementia.
In: Journal of neurology, vol 266, iss 8 (2019)
BASE
Show details
19
Language impairment in progressive supranuclear palsy and corticobasal syndrome ...
Peterson, Katie A.; Patterson, Karalyn; Rowe, James B.. - : Apollo - University of Cambridge Repository, 2019
BASE
Show details
20
The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy
In: ISSN: 2213-1582 ; NeuroImage: Clinical (2019) P. 102009 (2019)
BASE
Show details

Page: 1 2 3

Catalogues
0
0
0
0
0
0
0
Bibliographies
0
0
0
0
0
0
0
0
0
Linked Open Data catalogues
0
Online resources
0
0
0
0
Open access documents
44
0
0
0
0
© 2013 - 2024 Lin|gu|is|tik | Imprint | Privacy Policy | Datenschutzeinstellungen ändern